SONM Stock Forecast: DNA X, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 4 of 100 as at 1 Aug 2026 — in the weakest quartile.
SONM stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores DNA X, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (96): Smaller than most of the companies we track.
Value (1): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own DNA X, Inc. — and when they’d sell — is the membership.
SONM stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on SONM, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 May 2020 | B. Riley FBR | Maintains | Buy | — |
| 14 May 2020 | B. Riley Securities | Maintains | Buy | $7.00 → $3.00 |
| 31 Oct 2019 | Oppenheimer | Downgrade | Perform | — |
| 11 Sept 2019 | B. Riley | Maintains | Buy | — |
| 11 Sept 2019 | B. Riley Securities | Maintains | Buy | $18 → $7.00 |
| 18 July 2019 | B. Riley FBR | Initiates | Buy | — |
| 9 July 2019 | National Securities | Upgrade | Buy | — |
| 10 June 2019 | National Securities | Initiates | Neutral | — |
| 4 June 2019 | Oppenheimer | Initiates | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
SONM analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
DNA X, Inc. (SONM) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 10.1×
- Price / sales
- —
- Price / book
- −51.8×
- EV / EBITDA
- −1.3×
Cheaper than 59% of US stocks
Cheaper than 99% of US stocks
Cheaper than 69% of US stocks
- Revenue growth (YoY)
- −100.0%
- Earnings growth (YoY)
- 1284.3%
- Gross margin
- —
- Operating margin
- 0.0%
- Net margin
- 0.0%
Higher than 1% of US stocks
Higher than 98% of US stocks
Higher than 35% of US stocks
Higher than 30% of US stocks
- Return on equity
- 307.1%
- Return on assets
- −25.0%
- Dividend yield
- —
Higher than 99% of US stocks
Higher than 17% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
SONM vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SONM appears on the weeks it earns a place.
Frequently asked questions about SONM stock
How does Ticker Nerd's model rank SONM?
As at 1 Aug 2026, DNA X, Inc. ranks 4 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (96 of 100).
What is the SONM stock forecast for 2030?
No analyst covering DNA X, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SONM are extrapolating price history, which says nothing about the business.
How has SONM stock performed over the past year?
DNA X, Inc. returned -66.4% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does DNA X, Inc. do?
Sonim Technologies Inc. is a provider of ruggedized mobile phones, accessories, and connected solutions designed for task workers in demanding environments.
About DNA X, Inc.
Sonim Technologies Inc. is a provider of ruggedized mobile phones, accessories, and connected solutions designed for task workers in demanding environments. The company specializes in ultra-rugged devices such as the Sonim XP10, XP5plus, XP3plus, XP Pro 5G smartphones, and XP3plus 5G flip phones, along with mobile hotspots like the H100 and H700, and fixed wireless access products. These offerings include industrial-grade accessories like remote speaker microphones, charging solutions, and in-vehicle hands-free systems, as well as cloud-based software for enhanced productivity. Sonim Technologies Inc. serves sectors including first responders, military, government, construction, manufacturing, transportation, logistics, energy, utilities, hospitality, and facilities management, operating in the United States, Canada, Europe, the Middle East, Asia Pacific, Latin America, and Australia/New Zealand. Products are distributed through wireless carriers and channels, emphasizing durability, reliability, and mission-critical performance in extreme conditions. Founded in 1999 and headquartered in San Diego, California, Sonim Technologies Inc. focuses on enterprise 5G solutions and distraction-free communications for high-stakes professional use.
CEO Mr. Michael C. Mulica · 4 employees · United States · https://ir.dna-x.global